Shampa Das

Deputy Head of Department of Pharmacology and Therapeutics, University of Liverpool

Shampa Das (BSc, PhD) is a Professor of Antimicrobial Therapeutics at the University of Liverpool and PK-PD consultant. Following 17 years within the pharmaceutical industry, Shampa has extensive expertise in using PK-PD for developing Clinical Pharmacology and dose strategies to support the clinical development and regulatory approval of new anti-infective drugs. Within the Antimicrobial Pharmacodynamics and Therapeutics group at the University of Liverpool, Shampa supports biotech and pharma companies to develop new antimicrobial agents by developing the critical PK-PD package required for dose selection. Shampa is a serving member of the European Committee on Antimicrobial Susceptibility Testing (EUCAST steering committee for breakpoint decisions as PK-PD expert, a member of the CARBX Advisory board, and contributing expert for REVIVE by the Global Antibiotic Research and Development Partnership (GARDP).